| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/18/2004 | WO2004002983A3 Therapeutic piperazine derivatives useful for treating pain |
| 03/18/2004 | WO2004002239A3 Purified amylase inhibitor and novel process for obtaining the same |
| 03/18/2004 | WO2003099763A8 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 03/18/2004 | WO2003094830A3 Novel azacyclic ethynyl derivatives |
| 03/18/2004 | WO2003092684A8 TIME-RESOLVED FLUORESCENCE ASSAY FOR THE DETECTION OF MULTIMERIC FORMS OF A-β[BETA] OR OTHER AGGREGATING POLYPEPTIDES |
| 03/18/2004 | WO2003076461A3 Dimeric tf antagonist comprising two factor vii polypeptides |
| 03/18/2004 | WO2003070750A3 Rna interference mediated inhibition of hepatitis c virus |
| 03/18/2004 | WO2003070731A3 Azabicyclic compounds for the treatment of disease |
| 03/18/2004 | WO2003066595A3 2 - piperazine - pyridines useful for treating pain |
| 03/18/2004 | WO2003043571A3 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation |
| 03/18/2004 | WO2003042226A3 Single nucleotide polymorphisms in gh-1 |
| 03/18/2004 | WO2003041725A3 Regulation of cgmp-specific phosphodiesterase 9a |
| 03/18/2004 | WO2003041701A3 Preparation for improving the action of receptors |
| 03/18/2004 | WO2003035009A3 Treatment of acute myeloid leukemia with indolinone compounds |
| 03/18/2004 | WO2003033524A3 Peptidyl ketones as inhibitors of dpiv |
| 03/18/2004 | WO2003028630A3 Methods and compositions for modulating interleukin-21 receptor activity |
| 03/18/2004 | WO2003015704A3 Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders |
| 03/18/2004 | WO2002103029A3 Methods for sterilizing preparations of monoclonal immunoglobulins |
| 03/18/2004 | WO2002090567A9 Sperm-specific cation channel, and uses therefor |
| 03/18/2004 | US20040054480 Three dimensional structures and models of Fc receptors and uses thereof |
| 03/18/2004 | US20040054213 Ophthalmic compositions for treating ocular hypertension |
| 03/18/2004 | US20040054197 Styrene derivatives and process for production thereof |
| 03/18/2004 | US20040054187 Therapeutic ureas |
| 03/18/2004 | US20040054184 Preservative for organs, synthetic blood |
| 03/18/2004 | US20040054183 Thienopyridine derivatives, their production and use |
| 03/18/2004 | US20040054182 Antiinflammatory agents; rheumatic diseases; antiallergens; skin disorders; anticancer agents; antidiabetic agents |
| 03/18/2004 | US20040054180 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 03/18/2004 | US20040054179 Antiallergens; skin disorders; antitumor agents; tyrosine kinase inhibitor |
| 03/18/2004 | US20040054155 Oligonucleotide compositions with enhanced efficiency |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040054143 Vegf peptides and their use for inhibiting angiogenesis |
| 03/18/2004 | US20040054142 Cripto tumour polypeptide |
| 03/18/2004 | US20040054140 Neuronal differentiation regulating factor for treatment of central nervous system disorders |
| 03/18/2004 | US20040054014 Administering to subject at least one chemotherapeutic agent and at least one 3-aryloxy-3-phenylpropylamine; for multidrug resistance cancer |
| 03/18/2004 | US20040054005 Sodium channel blocker compositions and the use thereof |
| 03/18/2004 | US20040053998 For treating restenosis in tissue wherein smooth muscle cell migration occurs following angioplasty; for treatment of chronic inflammation, ischemic diseases and cancer |
| 03/18/2004 | US20040053993 Compositions of tocol-soluble therapeutics |
| 03/18/2004 | US20040053987 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 03/18/2004 | US20040053983 1, 2, 4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
| 03/18/2004 | US20040053982 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 03/18/2004 | US20040053981 Such as 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; fluorescent quantitative analysis; for treatment/prevention of cancer |
| 03/18/2004 | US20040053977 Such as N-pyridin-2-yl-N'-(1-pyridin-2-yl-ethylidene)hydrazine for increasing erythropoietin levels and vascularization of tissue; antihypoxic agents |
| 03/18/2004 | US20040053974 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 03/18/2004 | US20040053964 N-type calcium channel antagonists for the treatment of pain |
| 03/18/2004 | US20040053960 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 03/18/2004 | US20040053957 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization |
| 03/18/2004 | US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 03/18/2004 | US20040053947 Pyrrolo[2,3-D]pyrimidine compounds |
| 03/18/2004 | US20040053946 Cancer treatment method |
| 03/18/2004 | US20040053945 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative |
| 03/18/2004 | US20040053942 Fused pyrazole derivatives bieng protein kinase inhibitors |
| 03/18/2004 | US20040053941 Substituted pyrazine derivatives |
| 03/18/2004 | US20040053935 Anticancer agents |
| 03/18/2004 | US20040053934 Anticancer agents |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053931 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 03/18/2004 | US20040053929 1, 2, 5, 10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 03/18/2004 | US20040053924 Reacting pyrrolo(2,3-d)pyrimidin-4-one derivative containing a leaving group with a aromatic or heteroaromatic amine, hydroxy, marcaptan etc. in presence of a polar solvent and a catalyst |
| 03/18/2004 | US20040053921 Compounds useful as reversible inhibitors of cysteine proteases |
| 03/18/2004 | US20040053920 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 03/18/2004 | US20040053919 Administering a patient suffering from arthritic diseases, a 1,4-benzodiazapine or a 1,4-benzothiazepine derivative for treating such degenerative joint diseases |
| 03/18/2004 | US20040053918 Erythropoietin production potentiator |
| 03/18/2004 | US20040053909 Administering to a cancer patient a geldanamycin derivative containing dimethylaminoethylamine (at 17the position) group attached to the ring, for the treatment of cancer |
| 03/18/2004 | US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 03/18/2004 | US20040053898 For organ specific therapy; for treatment of menopausal symptoms, hormone-deficiency diseases and neurodegenerative diseases |
| 03/18/2004 | US20040053897 Selective androgen receptor modulators (SARMs); for inhibition of mitogenic action of testosterone and dihydrotestosterone; also for treatment of hair loss |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | US20040053874 Polynucleotide that hybridize with and inhibit gene expression for amphipathic dimeric glycoproteins |
| 03/18/2004 | US20040053872 Administering polynucletides that inhibit interactions polymerases with tRNA, to humans for prophylaxis of aquired immune deficiency syndrome |
| 03/18/2004 | US20040053869 Stem cell differentiation |
| 03/18/2004 | US20040053855 Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives |
| 03/18/2004 | US20040053853 Topiramate salts and compositions comprising and methods of making and using the same |
| 03/18/2004 | US20040053851 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 03/18/2004 | US20040053845 Modified peptides as therapeutic agents |
| 03/18/2004 | US20040053843 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 03/18/2004 | US20040053842 Cholesterol ester transfer protein inhibitors for use in treating atherosclerosis optionally in combination with other antihypertensive agents |
| 03/18/2004 | US20040053838 Measuring serum IGF-I and/or IGF-I binding protein levels after birth of patient to obtain IGF-I or IGF-I binding protein level and correlating said level with in utero baseline level based on gestational age matched mean levels |
| 03/18/2004 | US20040053828 Partial peptide mimetics and methods |
| 03/18/2004 | US20040053826 Uses of polypeptides |
| 03/18/2004 | US20040053820 Histone deacetylase inhibitor |
| 03/18/2004 | US20040053364 Genetically engineered immunoglobulin receptor for modulating humoral response in transplant patients |
| 03/18/2004 | US20040053325 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 03/18/2004 | US20040053316 Contacting composition with an aziridine derivative inactivating agent; killed virus-containing vaccines |
| 03/18/2004 | US20040053299 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 03/18/2004 | US20040053281 Comprises enzymatic polypeptide associated with fatty acid metabolism for diagnosing, treating and preventing cancer, neurodegenerative, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 03/18/2004 | US20040053278 Smad6 and uses thereof |
| 03/18/2004 | US20040053262 Supressor gene |
| 03/18/2004 | US20040053259 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer |
| 03/18/2004 | US20040053228 Apoptosis inhibitory polypeptides, gene and polynucleotide encoding it and compositions containing the same |
| 03/18/2004 | US20040053220 Replication assay for detecting anti-viral substances |
| 03/18/2004 | US20040053206 Using tissue preservation solution to decrease reperfusion injury of an organ during surgery and/or following removal of organ |
| 03/18/2004 | US20040052922 Nutritional and therapeutical preparations having antioxidant activity |
| 03/18/2004 | US20040052873 Bioavailability / bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 03/18/2004 | US20040052870 Cyclooxygenase (COX-2) inhibitors; for treatment/prevention of inflammation; nutraceuticals; for treatment of nervous system disorders |
| 03/18/2004 | US20040052869 Orally ingestible preparation of mistletoe lectins and method |
| 03/18/2004 | US20040052864 Comprises decitabine as methylation inhibitor; kits; tumor suppressor genes/proteins; interleukins; vaccines |
| 03/18/2004 | US20040052838 Erythropoietin liposomal dispersion |
| 03/18/2004 | US20040052835 Matrix controlled transdermal system for stabile derivatives of ace inhibitors |
| 03/18/2004 | US20040052796 Anticancer agents; antitumor agents; controlling gene expression; quantitative analysis |